HRQoL in patients with R/R CTCL treated with lacutamab in the TELLOMAK trial

(5:21)

Lacutamab in patients with advanced mycosis fungoides: results from the TELLOMAK trial

(3:18)

TELLOMAK: lacutamab alone or with chemotherapy in patients with mycosis fungoides or Sézary syndrome

(1:12)

Lacutamab for advanced mycosis fungoides: Are the early results promising?

(2:53)

ASH 2024: Dr. Porcu Discusses Patient-Reported Outcomes With Lacutamab in Cutaneous T-Cell Lymphoma

(12:26)

Lacutamab for CTCL

(1:27)

Updates on the TELLOMAK trial

(1:5)

TELLOMAK Clinical Trial Update - June 2022

(38:43)

Panel Discussion: TELLOMAK Clinical Trial

(41:28)

POTELIGEO and the CCR4 Target

(7:30)

Hello TELLOMAK: new trial for T-cell lymphoma

(1:15)

[ASMR] Innate Pharma : Biotechnologies, Cellules NK, Lacutamab et Anket

(3:25)

Foods for Mycosis Fungoides!

(1:48)

Sezary Syndrome

(2:23)

Clinical Case #2: Early-stage Mycosis Fungoides with worsening skin symptoms

(7:17)

Sezary Syndrome

(19)

Fungoides Mycosis and Sezary Syndrome

(1:23)

mycosis fungoides rare t cell lypmph skin disease cured dr stephen ferguson nd phd

(1:56)

Jeff's Journey: Mycosis Fungoides (patient)

(7:38)